ENDRA Life Sciences (NDRA) Liabilities and Shareholders Equity (2016 - 2021)
Historic Liabilities and Shareholders Equity for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $15.3 million.
- ENDRA Life Sciences' Liabilities and Shareholders Equity rose 18564.96% to $15.3 million in Q3 2021 from the same period last year, while for Dec 2021 it was $51.5 million, marking a year-over-year increase of 14058.53%. This contributed to the annual value of $8.8 million for FY2020, which is 2213.83% up from last year.
- According to the latest figures from Q3 2021, ENDRA Life Sciences' Liabilities and Shareholders Equity is $15.3 million, which was up 18564.96% from $17.2 million recorded in Q2 2021.
- Over the past 5 years, ENDRA Life Sciences' Liabilities and Shareholders Equity peaked at $18.9 million during Q1 2021, and registered a low of $545126.0 during Q1 2017.
- Over the past 5 years, ENDRA Life Sciences' median Liabilities and Shareholders Equity value was $5.4 million (recorded in 2020), while the average stood at $6.8 million.
- As far as peak fluctuations go, ENDRA Life Sciences' Liabilities and Shareholders Equity soared by 114779.72% in 2017, and later tumbled by 8272.78% in 2018.
- ENDRA Life Sciences' Liabilities and Shareholders Equity (Quarter) stood at $6.1 million in 2017, then grew by 17.95% to $7.2 million in 2018, then fell by 0.64% to $7.2 million in 2019, then grew by 22.14% to $8.8 million in 2020, then surged by 74.72% to $15.3 million in 2021.
- Its last three reported values are $15.3 million in Q3 2021, $17.2 million for Q2 2021, and $18.9 million during Q1 2021.